Associate Professor of Medicine
University of Colorado
Indianapolis, Indiana, United States
Dr. Shah is a Professor of Medicine, Division of Endocrinology & Metabolism and Director of Diabetes Clinical Research at the IU Center for Diabetes and Metabolic Diseases at Indiana University. His research is focused on improving glycemic control and reducing complications, with special interest in fracture prevention, in people with type 1 diabetes.
Dr. Shah has been the PI for many clinical trials of diabetes technologies and therapeutics. He has been a part of many landmark researches that led to FDA approval of newer devices and changed the type 1 diabetes management. Moreover, his interest in understanding the effect of diabetes on bone fragility had led to NIH-funded studies investigating effect of long-standing T1D on bone structural and tissue material properties in older adults with type 1 diabetes.
Dr. Shah has served in many leadership positions such as steering committee member for T1D Exchange Clinic Registry (2016-2017). He is currently serving as Chair-Elect, for the Diabetes Technology Interest Group and 83rd/84th Scientific Session Planning Committee at the American Diabetes Association and a writing committee member for the American College of Endocrinology Self-Assessment Program (2020-2022). He is the recipient of prestigious AACE Rising Star in Endocrinology Award (2021), ADA Diabetes Technology Interest Group Award (2022) and Diabetes Technology Society Leadership Award (2023).
He serves as the Editor-in-Chief for Clinical Diabetology, Senior Editor for the Endocrine Connections and on the Editorial Board for Diabetes Care. He is well published with over 170 research publications including original article, invited reviews, editorials, and book chapters.
Disclosure information not submitted.
Potential Utility of SGLT2i and GLP1RA in Type 1 DM: Why, When and How
Saturday, May 11, 2024
9:30 AM – 10:45 AM CDT